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Mouse mutagenesis: From gene to phenotype and back again
Rosa Beddington
Screens for genetic mutations have been instrumental
in identifying genes needed to execute particular
biological processes. They have also helped to resolve
the function of individual genes. Now the notion of
large-scale mutagenesis screens in mouse, an
experimental model for humans, is becoming a reality.
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At the heart of genetics lie screens for mutations that
cause detectable and heritable changes in biological form
or function. If altering a particular gene alters a biological
process, then probably that gene’s normal protein product
operates in that process. Genetic screens thus provide a
relatively unbiassed route for identifying the genes
required for a given biological process. They may also
indicate when in that process the product of a particular
gene is needed, and how it interacts with or relates to
other genes operating in the same process. In this way, a
hierarchy of genetic requirements can be compiled, even
before the molecular nature of the gene products is
known. Can large scale mutagenesis screens be used to
dissect mammalian biology?
The success of a genetic screen depends on several
factors. Scale is important: the phenotypes of enough
individuals need to be studied to ensure that mutations in
as many genes as possible — ideally, all genes — are
represented. Indeed, more than one mutation per gene is
desirable, different mutations exposing different facets of
function. In reality, however, some mutations will be
lethal before the phenotype is examined, which means
that the ideal of saturation is seldom realised. How sensi-
tive the screen will be depends on how good the criteria
are for distinguishing between normal and abnormal 
phenotype. Often it is easier to identify mutations in
organisms that otherwise have identical genomes and
minimal phenotypic variability between individuals.
The type of mutation being sought will also be important.
Removing or attenuating gene function generally reveals
more about normality than adding to or changing gene
function. If a plant is deprived of water, it will die because
normally it needs water. If it is given detergent it will also
die, not because normally it needs detergent, but because
the addition of soap changes water into a poison. So loss-
of-function mutations, which tend to be recessive in
diploid organisms, are usually more informative than gain-
of-function mutations, which tend to be dominant. The
ability to map mutations to their location in the genome
— on which chromosome they reside and where — is
essential, not only in helping to distinguish between dif-
ferent genes with similar effects, but also in cloning the
mutated gene and determining the molecular function of
its product.
The power of genetic screens in unravelling complex
biological processes is illustrated by the understanding of
cell proliferation that has been gained from the systematic
analysis of yeast mutants [1], and the counter-intuitive
revelations about pattern formation which emerged from
studying recessive mutations in fly embryos [2]. Are such
screens suited to animals with larger genomes — in
particular, mammals — in order to dissect their biological
peculiarities? The recent mutant screens of zebrafish
embryos bode well [3,4]. Hundreds of recessive mutations
affecting various developmental pathways have been
recovered, many of which may prove relevant to other
vertebrates. But no matter how plausible the inferences
drawn from zebrafish, these cannot substitute for a direct
analysis of mammalian biology.
Mice are the most accessible and prolific experimental
mammals and, apart from humans, the mammal whose
genetics are best understood. Despite this, mutations are
recognised in only about 2% of the anticipated 60,000
mouse genes. It is time to expand this resource, taking
advantage of the genetic homogeneity of existing inbred
strains of mice. Germline mutations, which will be passed
to subsequent generations, are usually induced in mice
either by manipulating the DNA of embryos or by chemi-
cally modifying the DNA of sperm in the adult. Targetting
mutations to specific genes by DNA manipulation is a
powerful tool in mice, but too laborious a method for satu-
rating the genome with mutations. Gene trap technology,
where DNA is randomly inserted into the genome but
only likely mutagenic insertions within gene sequences
are recovered, may be more suitable for mutating all genes.
But at present the most efficient mutagen in mice is the
alkylating agent ethylnitrosourea (ENU), which produces
predominantly point mutations in sperm. Tracing a
mutant phenotype induced by ENU to the gene in which
a single base-pair change has occurred requires formidable
knowledge of the genome. The absolute benefit of
genome-wide ENU mutagenesis screens therefore
depends critically on the speed, accuracy and resolution
with which a comprehensive physical map of the mouse
genome is generated.
Large-scale mutagenesis screens in mice are now under
way (reviewed in [5]). There are phenotype-based screens
looking for mutations that disrupt specific processes. These
are particularly apposite where it is not possible to study
the process in depth in the human population. Embryogen-
esis is an obvious example. Behavioural mutants might be
another, although it is salutary to consider that behavioural
genetics in flies has pointed more to an ignorance of how
the central nervous system develops than how it operates
[6]. There are also genome-based screens that are
prompted by the pressing need to determine the function
of all genes in the genome. The Human Genome Project
will soon have determined the DNA sequences encoding
the full repertoire of proteins needed to make a human
being. Systematically mutating every gene in the mouse
genome and documenting the consequences for the animal
is one way of deciphering what these genes do.
Most genome-wide searches for mutations affecting
mouse biology focus on identifying dominant 
mutations whose phenotypes can be detected in viable 
mice. The immediate offspring of males injected with 
ENU are subjected to a series of tests designed to expose
defects in a variety of organ systems, ranging from 
motor function to hearing to blood composition (for 
example, see http:/www.mgu.har.mrc.ac.uk/mutabase/ or
http://www.gsf.de/isg/groups/enu/mutants/index.html). It
is too early to judge what the rewards will be from these
screens. Cynics might argue that the human population
already offers the best resource for identifying dominant
traits. Moreover, dominant mutations in some genes will
be incompatible with viability, and some phenotypes may
stem from fortuitous combinations of several mutations.
There is also the problem that, if dominance is due to
changing the function of a gene product, this may not
greatly illuminate what it normally does. Nonetheless, this
approach has already borne important fruit: Clock, the first
mutation known to disrupt circadian rhythm in a mammal,
was identified from a dominant screen [7].
Recessive screens have been carried out in mice by crossing
mutagenised males, or their offspring, with animals that
already carry a deletion in their genome [5]. In this way, only
one copy of each gene within the deletion is present and
inherited from the mutagenised mouse, so if one of these
genes has been mutated, a recessive phenotype will be
exposed. Although a collection of deletions exists amongst
mouse stocks, this can now be expanded and tailored by
physical or molecular chromosome engineering in embry-
onic stem cells [8,9]. Although it is unlikely that a deletion
series can be generated that covers the whole genome, well-
designed phenotype screens should permit the functions of
many chromosomal regions to be pieced together.
What about phenotype-based genome-wide recessive
screens? These are few and far between, the search for
Dispatch R841
Figure 1
A phenotype-based genome-wide
mutagenesis screen for recessive mutations
affecting mammalian embryonic development.
*
*
*** X
X
X
*
**++
+
37.5%                                 50%                                12.5%
Current Biology   
Mutagenised male
(carrying many
different mutations)
mated to
wild-type female
Individual male progeny
mated to wild-type females
to found individual families
Female progeny
mated back to 
father (half the females should
be heterozygous for mutation)
Phenotype of embryos 
assessed: 1 in 8 embryos
should be homozygous
for mutation
+
+
+
+
+ +
+
+
ENU
R842 Current Biology, Vol 8 No 23
recessive mutations affecting phenylalanine metabolism
being the most notable until recently [10]. This summer,
Karsakis et al. [11] published a study aimed at assessing
the feasibility of screening the mouse genome for
recessive mutations that affect embryonic pattern at mid-
gestation. As many adult anomalies stem from develop-
mental defects, and many molecular pathways are first
used during development, a screen for such embryonic
phenotypes is a brave but judicious beginning. 
Karsakis et al. [11] looked for phenotypes at a stage when
most mutant embryos with patterning defects should still
be alive and identifiable from inspection in a dissecting
microscope (Figure 1). Out of 130 separate families, only
86 produced enough second generation females for
screening embryonic progeny. Five mutant lines —
approximately 6% of the total — were identified. One of
these had a complex genetic basis, but the other four
mutations each mapped to single loci and behaved as
simple recessive traits. Two mutations affected closure of
the neural tube — one of which proved to be allelic to an
existing spontaneous mutation — while the other two
caused earlier and more widespread defects. 
The importance of this study is that it demonstrates the
feasibility of a genome-wide search for recessive genes
affecting development, and the relative ease with which
mutations can be mapped (and, hopefully, soon cloned).
If ENU produces one new mutation per gene for every
700 mutagenised families screened, then it is reasonable
to suppose that screening a mere 1000 families will
reveal most genes in which mutations give recognisable
midgestation embryonic phenotypes. This is not such a
daunting prospect, especially once the physical genome
map is complete.
The attraction of phenotype-based screens is that they are
not just about gene discovery, but rather about gene inter-
action and the genetic networks which dictate form and
function. In this gene obsessed age, it is important to
remember that the genetic harvest is not just a dictionary
of gene sequences, but also a compendium of phenotypes.
Biologists have to be committed to studying a new genera-
tion of mouse mutants and using these phenotypes to
interpret the language of the genes. 
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